glucose, (beta-d)-isomer has been researched along with Sclerosis, Systemic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fleischanderl, S; Foerster, J; Pfeiffer, S; Riemekasten, G; Storch, A; Wittstock, S; Worm, M | 1 |
| Bai, J; Fan, G; Li, S; Liu, R | 1 |
2 other study(ies) available for glucose, (beta-d)-isomer and Sclerosis, Systemic
| Article | Year |
|---|---|
Neutrophil respiratory burst is decreased in scleroderma and normalized by near-infrared mediated hyperthermia.
Topics: Adult; Aged; Case-Control Studies; Dose-Response Relationship, Drug; Female; Humans; Hyperthermia, Induced; Infrared Rays; Male; Middle Aged; Monocytes; Neutrophils; Reactive Oxygen Species; Respiratory Burst; Scleroderma, Systemic; Severity of Illness Index; Tetradecanoylphorbol Acetate; Tissue Culture Techniques; Zymosan | 2006 |
Total glucosides of paeony alleviates scleroderma by inhibiting type I interferon responses.
Topics: Animals; Autoimmune Diseases; Bleomycin; Cytokines; Glucosides; Interferon Type I; Mice; Paeonia; Scleroderma, Systemic | 2023 |